Alleviation of high fat diet-induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium longum

Molecular Nutrition and Food Research

Volumn 59, Issue 11, 2015, Pages 2267-2278

  Woting, Anni ^a   Pfeiffer, Nora ^a   Hanske, Laura ^a   Loh, Gunnar ^a   Klaus, Susanne ^a   Blaut, Michael ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Bifidobacterium longum; Diet induced obesity; Glucose tolerance; Metabolic endotoxemia; Oligofructose

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; LIPOPOLYSACCHARIDE; OLIGOSACCHARIDE;

ANIMAL; BIFIDOBACTERIUM; BLOOD; BODY COMPOSITION; C3H MOUSE; GERMFREE ANIMAL; LIPID DIET; MOUSE; OBESITY; PHYSIOLOGY;

ADIPOSITY; ANIMALS; BIFIDOBACTERIUM; BODY COMPOSITION; DIET, HIGH-FAT; GERM-FREE LIFE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C3H; OBESITY; OLIGOSACCHARIDES;

EID: 84940525668     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500249     Document Type: Article

References (62)

1. World Health Organization. Obesity and overweight. Fact Sheet N°311 [updated August 2014; cited 8-10-14]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.
2. Bleich, S., Cutler, D., Murray, C., Adams, A. et al., Why is the developed world obese? Ann.Rev. Public Health 2008, 29, 273-295.
3. Peeters, A., Backholer, K., Is the health burden associated with obesity changing? Am. J. Epidemiol. 2012, 176, 840-845.
4. Wells, J. C., The evolution of human adiposity and obesity: where did it all go wrong? Dis. Models Mech. 2012, 5, 595-607.
5. Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A. et al., Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102, 11070-11075.
6. Backhed, F., Crawford, P. A., O'Donnell, D., Gordon, J. I., et al., Postnatal lymphatic partitioning from the blood vasculature in the small intestine requires fasting-induced adipose factor. Proc. Natl. Acad. Sci. USA 2007, 104, 606-611.
7. Backhed, F., Ding, H., Wang, T., Hooper, L. V. et al., The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101, 15718-15723.
8. Munukka, E., Wiklund, P., Pekkala, S., Volgyi, E. et al., Women with and without metabolic disorder differ in their gut microbiota composition. Obesity 2012, 20, 1082-1087.
9. InterAct, C., Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies. Diabetologia 2015, 58, 1394-1408.
10. Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C. et al., Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50, 2374-2383.
11. Cani, P. D., Possemiers, S., Vande Wiele, T., Guiot, Y. et al., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58, 1091-1103.
12. Everard, A., Lazarevic, V., Derrien, M., Girard, M. et al., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60, 2775-2786.
13. Neyrinck, A. M., Possemiers, S., Druart, C., Vande Wiele, T. et al., Prebiotic effects of wheat arabinoxylan related to the increase in bifidobacteria, Roseburia and Bacteroides/Prevotella in diet-induced obese mice. PLoS One 2011, 6, e20944.
14. Neyrinck, A. M., VanHee, V. F., Piront, N., DeBacker, F. et al., Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr.Diabetes 2012, 2, e28.
15. Parnell, J. A., Reimer, R. A., Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 2012, 3, 29-34.
16. Parnell, J. A., Reimer, R. A., Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br. J. Nutr. 2012, 107, 601-613.
17. Anastasovska, J., Arora, T., Sanchez Canon, G. J., Parkinson, J. R. et al., Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment. Obesity 2012, 20, 1016-1023.
18. Collado, M. C., Isolauri, E., Laitinen, K., Salminen, S., Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am. J. Clin. Nutr. 2008, 88, 894-899.
19. Kalliomaki, M., Collado, M. C., Salminen, S., Isolauri, E., Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 2008, 87, 534-538.
20. Wu, X., Ma, C., Han, L., Nawaz, M. et al., Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 2010, 61, 69-78.
21. Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M. et al., Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
22. Cani, P. D., Knauf, C., Iglesias, M. A., Drucker, D. J. et al., Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 2006, 55, 1484-1490.
23. Wang, Z. T., Yao, Y. M., Xiao, G. X., Sheng, Z. Y. et al., Risk factors of development of gut-derived bacterial translocation in thermally injured rats. World J. Gastroenterol. 2004, 10, 1619-1624.
24. Griffiths, E. A., Duffy, L. C., Schanbacher, F. L., Qiao, H. et al., In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig. Dis. Sci. 2004, 49, 579-589.
25. Wang, Z., Xiao, G., Yao, Y., Guo, S. et al., The role of bifidobacteria in gut barrier function after thermal injury in rats. J. Trauma 2006, 61, 650-657.
26. Putaala, H., Salusjarvi, T., Nordstrom, M., Saarinen, M. et al., Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res. Microbiol. 2008, 159, 692-698.
27. Becker, N., Kunath, J., Loh, G., Blaut, M. et al., Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes 2011, 2, 25-33.
28. Woting, A., Pfeiffer, N., Loh, G., Klaus, S. et al., Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. mBio 2014, 5, e01530-e01514.
29. Fleissner, C. K., Huebel, N., Abd El-Bary, M. M., Loh, G. et al., Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 2010, 104, 919-929.
30. Cani, P. D., Bibiloni, R., Knauf, C., Waget, A. et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57, 1470-1481.
31. Klaus, S., Rudolph, B., Dohrmann, C., Wehr, R. et al., Expression of uncoupling protein 1 in skeletal muscle decreases muscle energy efficiency and affects thermoregulation and substrate oxidation. Physiol. Genomics 2005, 21, 193-200.
32. Matsuki, T., Watanabe, K., Fujimoto, J., Kado, Y. et al., Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol. 2004, 70, 167-173.
33. Junick, J., Blaut, M., Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl. Environ. Microbiol. 2012, 78, 2613-2622.
34. Slezak, K., Hanske, L., Loh, G., Blaut, M., Increased bacterial putrescine has no impact on gut morphology and physiology in gnotobiotic adolescent mice. Beneficial Microbes 2013, 4, 253-266.
35. Weber, K., Bolander, M. E., Sarkar, G., PIG-B: a homemade monophasic cocktail for the extraction of RNA. Mol. Biotechnol. 1998, 9, 73-77.
36. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29, e45.
37. Brun, P., Castagliuolo, I., Di Leo, V., Buda, A. et al., Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292, G518-G525.
38. Maukonen, J., Matto, J., Suihko, M. L., Saarela, M. et al., Intra-individual diversity and similarity of salivary and faecal microbiota. J. Med. Microbiol. 2008, 57, 1560-1568.
39. Zoetendal, E. G., vonWright, A., Vilpponen-Salmela, T., Ben-Amor, K. et al., Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 2002, 68, 3401-3407.
40. McCracken, V. J., Simpson, J. M., Mackie, R. I., Gaskins, H. R. et al., Molecular ecological analysis of dietary and antibiotic-induced alterations of the mouse intestinal microbiota. J. Nutr. 2001, 131, 1862-1870.
41. Fushuku, S., Fukuda, K., Gender difference in the composition of fecal flora in laboratory mice, as detected by denaturing gradient gel electrophoresis (DGGE). Exp. Anim. 2008, 57, 489-493.
42. Friswell, M. K., Gika, H., Stratford, I. J., Theodoridis, G. et al., Site and strain-specific variation in gut microbiota profiles and metabolism in experimental mice. PLoS One 2010, 5, e8584.
43. Loh, G., Brodziak, F., Blaut, M., The Toll-like receptors TLR2 and TLR4 do not affect the intestinal microbiota composition in mice. Environ. Microbiol. 2008, 10, 709-715.
44. Nishikawa, S., Yasoshima, A., Doi, K., Nakayama, H. et al., Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL/6J and BALB/cA mice. Exp. Anim. 2007, 56, 263-272.
45. Montgomery, M. K., Hallahan, N. L., Brown, S. H., Liu, M. et al., Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding. Diabetologia 2013, 56, 1129-1139.
46. Parks, B. W., Nam, E., Org, E., Kostem, E. et al., Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 2013, 17, 141-152.
47. Falony, G., Calmeyn, T., Leroy, F., DeVuyst, L. et al., Coculture fermentations of Bifidobacterium species and Bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans. Appl. Environ. Microbiol. 2009, 75, 2312-2319.
48. Falony, G., Verschaeren, A., DeBruycker, F., DePreter, V. et al., In vitro kinetics of prebiotic inulin-type fructan fermentation by butyrate-producing colon bacteria: implementation of online gas chromatography for quantitative analysis of carbon dioxide and hydrogen gas production. Appl. Environ. Microbiol. 2009, 75, 5884-5892.
49. Falony, G., Vlachou, A., Verbrugghe, K., DeVuyst, L., et al., Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl. Environ. Microbiol. 2006, 72, 7835-7841.
50. Mazzon, E., Cuzzocrea, S., Role of TNF-alpha in ileum tight junction alteration in mouse model of restraint stress. Am. J. Physiol. Gastrointest. Liver. Physiol. 2008, 294, G1268-G1280.
51. Fei, N., Zhao, L., An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013, 7, 880-884.
52. Kless, C., Muller, V. M., Schuppel, V. L., Lichtenegger, M. et al., Diet-induced obesity causes metabolic impairment independent of alterations in gut barrier integrity. Mol. Nutr. Food Res. 2015, 59, 968-978.
53. Verdam, F. J., Fuentes, S., deJonge, C., Zoetendal, E. G. et al., Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity 2013, 21, E607-E615.
54. Everard, A., Lazarevic, V., Gaia, N., Johansson, M. et al., Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 2014, 8, 2116-2130.
55. Dewulf, E. M., Cani, P. D., Claus, S. P., Fuentes, S. et al., Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 2013, 62, 1112-1121.
56. Ramirez-Farias, C., Slezak, K., Fuller, Z., Duncan, A. et al., Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101, 541-550.
57. Antal, M., Regoly-Merei, A., Biro, L., Arato, G. et al., Effects of oligofructose containing diet in obese persons. Orvosi. Hetilap. 2008, 149, 1989-1995.
58. Parnell, J. A., Reimer, R. A., Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 2009, 89, 1751-1759.
59. Jackson, K. G., Taylor, G. R., Clohessy, A. M., Williams, C. M. et al., The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br. J. Nutr. 1999, 82, 23-30.
60. Balcazar-Munoz, B. R., Martinez-Abundis, E., Gonzalez-Ortiz, M., Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Revista Med. de Chile 2003, 131, 597-604.
61. Delzenne, N. M., Kok, N., Effects of fructans-type prebiotics on lipid metabolism. Am. J. Clin. Nutr. 2001, 73, 456S-458S.
62. Kok, N., Roberfroid, M., Robert, A., Delzenne, N. et al., Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br. J. Nutr. 1996, 76, 881-890.